Galera Therapeutics, Inc. — All Filings
325 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
25-NSE
3
4
4/A
424B4
424B5
425
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001563577-26-000005 | Mar 19, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-055919 | Feb 18, 2026 | Feb 12, 2026 |
| 8-K | 8-K | 0001193125-26-048696 | Feb 12, 2026 | Feb 6, 2026 |
| 4 | — | 0000905148-25-004171 | Nov 24, 2025 | Nov 20, 2025 |
| 144 | — | 0001974078-25-000433 | Nov 20, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-278816 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-250698 | Oct 27, 2025 | Oct 21, 2025 |
| 8-K | 8-K | 0001193125-25-245093 | Oct 21, 2025 | — |
| 8-K | 8-K | 0001193125-25-194948 | Sep 3, 2025 | Aug 27, 2025 |
| 10-Q | 10-Q | 0000950170-25-107616 | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-071956 | May 15, 2025 | Mar 31, 2025 |
| 4 | — | 0000905148-25-001449 | May 5, 2025 | May 1, 2025 |
| 4 | — | 0000905148-25-001448 | May 5, 2025 | May 1, 2025 |
| 8-K | 8-K | 0001193125-25-071428 | Apr 2, 2025 | Mar 31, 2025 |
| 10-K | 10-K | 0000950170-25-047798 | Mar 31, 2025 | Dec 31, 2024 |
| 8-K/A | 8-K/A | 0001193125-25-060802 | Mar 24, 2025 | Dec 30, 2024 |
| 4 | — | 0000905148-25-000790 | Feb 26, 2025 | Feb 24, 2025 |
| 4 | — | 0000905148-25-000788 | Feb 26, 2025 | Feb 24, 2025 |
| 4 | — | 0000905148-25-000786 | Feb 26, 2025 | Feb 24, 2025 |
| 4 | — | 0000905148-25-000784 | Feb 26, 2025 | Feb 24, 2025 |
| 8-K | 8-K | 0001193125-25-035114 | Feb 25, 2025 | Feb 24, 2025 |
| SCHEDULE 13G | — | 0000950170-25-020864 | Feb 14, 2025 | — |
| DEF 14A | DEF 14A | 0001193125-25-011837 | Jan 24, 2025 | Feb 24, 2025 |
| D | — | 0000950123-25-000263 | Jan 14, 2025 | — |
| D | — | 0000950123-25-000248 | Jan 13, 2025 | — |
| 4 | — | 0000905148-25-000010 | Jan 2, 2025 | Dec 30, 2024 |
| 3 | — | 0000905148-25-000009 | Jan 2, 2025 | Dec 30, 2024 |
| 4 | — | 0000905148-25-000008 | Jan 2, 2025 | Dec 30, 2024 |
| 3 | — | 0000905148-25-000007 | Jan 2, 2025 | Dec 30, 2024 |
| 8-K | 8-K | 0001193125-24-287073 | Dec 31, 2024 | Dec 30, 2024 |
| 8-K | 8-K | 0001193125-24-283187 | Dec 20, 2024 | — |
| 10-Q | 10-Q | 0001193125-24-277849 | Dec 13, 2024 | Sep 30, 2024 |
| NT 10-Q | NT 10-Q | 0001193125-24-259961 | Nov 15, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001193125-24-239251 | Oct 18, 2024 | Oct 17, 2024 |
| 25-NSE | — | 0001354457-24-000643 | Sep 6, 2024 | — |
| 8-K | 8-K | 0001193125-24-212627 | Sep 4, 2024 | Aug 31, 2024 |
| DEF 14A | DEF 14A | 0001193125-24-211527 | Sep 3, 2024 | Oct 17, 2024 |
| PRE 14A | PRE 14A | 0001193125-24-205689 | Aug 23, 2024 | Oct 17, 2024 |
| 4 | 4 | 0000950170-24-099168 | Aug 20, 2024 | Aug 16, 2024 |
| 144 | — | 0001974078-24-000290 | Aug 16, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-096654 | Aug 14, 2024 | Jun 30, 2024 |
| 425 | 425 | 0001193125-24-200225 | Aug 14, 2024 | — |
| 8-K | 8-K | 0001193125-24-200220 | Aug 14, 2024 | — |
| 8-K | 8-K | 0001193125-24-196457 | Aug 8, 2024 | — |
| 8-K | 8-K | 0001193125-24-156660 | Jun 7, 2024 | Jun 4, 2024 |
| 8-K | 8-K | 0001193125-24-152343 | Jun 3, 2024 | May 31, 2024 |
| 3 | — | 0001213900-24-044072 | May 16, 2024 | Apr 16, 2024 |
| SC 13G/A | AMENDMENT NO. 2 TO FORM SC 13G | 0001213900-24-044071 | May 16, 2024 | — |
| SC 13G | SCHEDULE 13G | 0001213900-24-044069 | May 16, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-058197 | May 13, 2024 | Mar 31, 2024 |